Right Treatment for the Right Patient at the Right Time

Improve access to necessary testing to help more Californians effectively treat cancer

Biomarker testing, which identifies markers like mutations, is key to connecting many cancer patients with the most effective treatment for their disease. 

Why is ensuring equitable access to biomarker testing important?

  • Targeted therapies based on the results of biomarker testing, can lead to improved survivorship and better quality of life for cancer patients. 
  • Insurance coverage for biomarker testing is failing to keep pace with innovations and advancements in treatment preventing all communities from benefiting from the latest advancements in biomarker testing and precision medicine.

Join ACS CAN in calling on the California legislature to require appropriate coverage of biomarker testing for public and private insurance plans.

Thank you for taking action! 

If you want to get more involved in the work ACS CAN California is doing to improve access to this important testing, we invite you to follow us on social media for updates and action opportunities.